A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies-Reference-Cited by-同舟云学术

A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies

Published:2009-03 Issue:3 Volume:20 Page:513-519
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Moreau M.,Klastersky J.,Schwarzbold A.,Muanza F.,Georgala A.,Aoun M.,Loizidou A.,Barette M.,Costantini S.,Delmelle M.,Dubreucq L.,Vekemans M.,Ferrant A.,Bron D.,Paesmans M.

Funder

National pour la Recherche Scientifique

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/20/3/513/457684/mdn655.pdf

Reference30 articles.

1. A predictive model for life-threatening neutropenia and febrile neutropenia after the first course of CHOP chemotherapy in patients with aggressive non-Hodgkin's lymphoma;Intragumtornchai;Leuk Lymphoma,2000

2. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial;Pettengell;Blood,1992

3. A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy;Green;Ann Oncol,2003

4. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline;Smith;J Clin Oncol,2006

5. Risk models for predicting chemotherapy-induced neutropenia;Lyman;Oncologist,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation;Current Opinion in Infectious Diseases;2024-07-31

2. A retrospective study on the analysis of influencing factors of neutropenia in endometrial cancer with adjuvant chemoradiotherapy;Radiation Oncology;2024-06-18

3. Healthy tissue metabolism assessed by [18F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients;Scientific Reports;2024-06-01

4. PREVALENCE AND PREDICTIVE FACTORS OF NEUTROPENIA AMONG PATIENTS WITH BREAST CANCER RECEIVING DOXORUBICINCYCLOPHOSPHAMIDE CHEMOTHERAPY AT A CANCER CENTER, SURIN HOSPITAL: A RETROSPECTIVE CASE-CONTROL STUDY;Journal of Southeast Asian Medical Research;2024-04-18

5. Healthy Tissue Metabolism Assessed by [18F]FDG PET/CT as a Marker of Prognosis and Adverse Events in Advanced Hodgkin Lymphoma Patients;2024-02-21